uniQure N.V. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
uniQure N.V. (QURE) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $3.90 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-05-05
- uniQure N.V. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $3.90M.
- uniQure N.V. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$14.85M.
- uniQure N.V. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $22.59M, a 537.32% increase year-over-year.
- uniQure N.V. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-06-30 was -$2.07M, a 171.70% decline year-over-year.
- uniQure N.V. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $4.47M.
- uniQure N.V. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$5.64M.
- uniQure N.V. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$5.33M, a 257.40% decline from fiscal 2022.
- uniQure N.V. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $3.38M, a 63.22% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $3.90M 10-Q · filed 2026-05-05 | -$10.95M derived: sum of 2 quarters · filed 2026-05-05 | $11.64M derived: sum of 3 quarters · filed 2026-05-05 | $9.58M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-12-31 | -$14.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $7.75M derived: sum of 2 quarters · filed 2026-03-02 | $5.68M derived: sum of 3 quarters · filed 2026-03-02 | $4.47M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $22.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $20.53M derived: sum of 2 quarters · filed 2025-11-10 | $19.32M 10-Q · filed 2025-11-10 | $15.36M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-06-30 | -$2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$3.27M 10-Q · filed 2025-07-29 | -$7.23M derived: sum of 3 quarters · filed 2026-05-05 | -$3.68M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-03-31 | -$1.21M 10-Q · filed 2026-05-05 | -$5.16M derived: sum of 2 quarters · filed 2026-05-05 | -$1.62M derived: sum of 3 quarters · filed 2026-05-05 | $1.27M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$412.00K derived: sum of 2 quarters · filed 2026-03-02 | $2.47M derived: sum of 3 quarters · filed 2026-03-02 | -$5.64M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $6.43M derived: sum of 2 quarters · filed 2025-11-10 | -$1.69M 10-Q · filed 2025-11-10 | -$6.08M 10-Q · filed 2024-11-05 | -$1.01M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$5.23M 10-Q · filed 2025-07-29 | -$7.90M 10-Q · filed 2024-08-01 | -$4.55M derived: sum of 3 quarters · filed 2026-03-02 | $858.00K derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | -$8.11M 10-Q · filed 2025-05-09 | -$9.55M 10-Q · filed 2024-05-07 | -$7.43M derived: sum of 2 quarters · filed 2026-03-02 | -$2.02M derived: sum of 3 quarters · filed 2026-03-02 | -$4.44M derived: sum of 4 quarters · filed 2026-03-02 | |||
| 2023-12-31 | $679.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $6.09M derived: sum of 2 quarters · filed 2026-03-02 | $3.68M derived: sum of 3 quarters · filed 2026-03-02 | -$5.33M 10-K · filed 2026-03-02 | -$6.64M 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $5.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $3.00M derived: sum of 2 quarters · filed 2024-11-05 | -$6.01M 10-Q · filed 2024-11-05 | -$6.25M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$11.42M 10-Q · filed 2024-08-01 | -$11.66M derived: sum of 3 quarters · filed 2025-02-27 | -$6.73M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$9.01M 10-Q · filed 2024-05-07 | -$9.25M derived: sum of 2 quarters · filed 2025-02-27 | -$4.32M derived: sum of 3 quarters · filed 2025-02-27 | $458.00K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.68M derived: sum of 2 quarters · filed 2025-02-27 | $9.46M derived: sum of 3 quarters · filed 2025-02-27 | $3.38M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $9.71M derived: sum of 2 quarters · filed 2023-11-07 | $3.63M 10-Q · filed 2023-11-07 | $1.25M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $4.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$1.30M 10-Q · filed 2023-08-01 | -$3.69M derived: sum of 3 quarters · filed 2024-02-28 | $2.42M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | -$6.08M 10-Q · filed 2023-05-09 | -$8.47M derived: sum of 2 quarters · filed 2024-02-28 | -$2.36M derived: sum of 3 quarters · filed 2024-02-28 | -$176.00K derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.72M derived: sum of 2 quarters · filed 2024-02-28 | $5.90M derived: sum of 3 quarters · filed 2024-02-28 | $9.20M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $8.29M derived: sum of 2 quarters · filed 2022-11-02 | $11.59M 10-Q · filed 2022-11-02 | $11.16M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.49M 10-Q · filed 2022-08-08 | $5.05M derived: sum of 3 quarters · filed 2023-02-27 | $10.02M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $3.30M 10-Q · filed 2022-05-02 | $2.87M derived: sum of 2 quarters · filed 2023-02-27 | $7.83M derived: sum of 3 quarters · filed 2023-02-27 | $9.15M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $4.53M derived: sum of 2 quarters · filed 2023-02-27 | $5.84M derived: sum of 3 quarters · filed 2023-02-27 | $3.20M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $4.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-25 | $6.28M derived: sum of 2 quarters · filed 2021-10-25 | $3.63M 10-Q · filed 2021-10-25 | $4.71M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26 | -$1.33M 10-Q · filed 2021-07-26 | -$256.00K derived: sum of 3 quarters · filed 2022-02-25 | $5.34M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | -$2.65M 10-Q · filed 2021-05-10 | -$1.57M derived: sum of 2 quarters · filed 2022-02-25 | $4.02M derived: sum of 3 quarters · filed 2022-02-25 | $4.55M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $6.67M derived: sum of 2 quarters · filed 2022-02-25 | $7.20M derived: sum of 3 quarters · filed 2022-02-25 | $6.01M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $6.12M derived: sum of 2 quarters · filed 2020-10-27 | $4.93M 10-Q · filed 2020-10-27 | $6.11M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$658.00K 10-Q · filed 2020-07-30 | $519.00K derived: sum of 3 quarters · filed 2021-03-01 | -$1.25M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$1.19M 10-Q · filed 2020-04-29 | -$13.00K derived: sum of 2 quarters · filed 2021-03-01 | -$1.78M derived: sum of 3 quarters · filed 2021-03-01 | $1.08M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$590.00K derived: sum of 2 quarters · filed 2021-03-01 | $2.27M derived: sum of 3 quarters · filed 2021-03-01 | -$382.00K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | -$1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $1.10M derived: sum of 2 quarters · filed 2019-10-28 | -$1.56M 10-Q · filed 2019-10-28 | -$1.87M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $208.00K 10-Q · filed 2019-07-29 | -$101.00K derived: sum of 3 quarters · filed 2020-03-02 | -$736.00K derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$2.66M 10-Q · filed 2019-04-29 | -$2.96M derived: sum of 2 quarters · filed 2020-03-02 | -$3.60M derived: sum of 3 quarters · filed 2020-03-02 | -$1.71M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$944.00K derived: sum of 2 quarters · filed 2020-03-02 | $944.00K derived: sum of 3 quarters · filed 2020-03-02 | -$1.64M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | -$635.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.25M derived: sum of 2 quarters · filed 2018-11-06 | -$1.33M 10-Q · filed 2018-11-06 | -$2.86M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$696.00K 10-Q · filed 2018-08-08 | -$2.23M derived: sum of 3 quarters · filed 2019-02-28 | -$3.18M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$2.58M 10-Q · filed 2018-04-30 | -$4.11M derived: sum of 2 quarters · filed 2019-02-28 | -$5.07M derived: sum of 3 quarters · filed 2019-02-28 | -$1.81M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$2.48M derived: sum of 2 quarters · filed 2019-02-28 | $775.00K derived: sum of 3 quarters · filed 2019-02-28 | $499.00K 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | -$953.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $2.31M derived: sum of 2 quarters · filed 2017-11-01 | $2.03M 10-Q · filed 2017-11-01 | |||||
| 2016-06-30 | $3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.98M 10-Q · filed 2017-08-08 | ||||||
| 2016-03-31 | -$276.00K 10-Q · filed 2017-05-09 | |||||||
| 2015-12-31 | $4.93M 10-K · filed 2018-03-14 | |||||||
| 2014-12-31 | $1.80M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |